Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesRadiology/Diagnostic ImagingHighmark PA Breast MRI Coverage Update | OpenPayer
    Ask Trek AI about this page
    CurrentHighmark PennsylvaniaPolicy X-44

    Magnetic Resonance Imaging (MRI) of the Breast

    Customize your policy alerts

    Sign up for Highmark Pennsylvania Policy X-44 alerts

    Get alerted when Policy X-44 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines clinical indications, coverage stance, coding and payment guidance for breast MRI for Highmark Pennsylvania commercial members; applies to professional and facility claims and outpatient place of service, with special inpatient exceptions.

    Policy Summary
    PayerHighmark Pennsylvania
    PolicyMagnetic Resonance Imaging (MRI) of the Breast
    Policy CodePolicy X-44
    Change TypeNo material change
    Effective DateMar 7, 2016
    Last ReviewMar 7, 2016
    Next Review DateN/A
    Key ActionSubmit professional claims on a pre-payment basis and provide documentation when MRI and CT of the same anatomic area are performed the same day to justify payment for both studies.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    ANY ONEindication(s) required for medical necessity
    77058,77059listed primary MRI CPT codes

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    A9576-A9579
    listed contrast HCPCS codes
    0159TCAD code non-covered
    Outpatienttypical place of service

    Coverage Criteria

    Medically Necessary Indications

    Covered when ANY ONE of the following is present

    Known BRCA mutation or high risk for BRCA mutation: Known BRCA1 or BRCA2 mutation, or at high risk of BRCA1 or BRCA2 mutation due to a known presence of the mutation in relatives

    from policy indications

    Hereditary cancer syndromes: Li-Fraumeni syndrome, Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome

    from policy indications

    First-degree relative with listed syndrome: Persons who have a first-degree relative with one of these syndromes

    from policy indications

    High lifetime risk by model: High risk (lifetime risk about 20% to 25% or greater) of developing breast cancer as identified by risk models largely defined by family history (e.g., Claus, modified Gail, Tyrer-Cuzick, BRCAPRO)>=20%

    from policy indications

    Prior chest radiation: Persons who received radiation therapy to the chest between 10 and 30 years of age

    from policy indications

    Personal history of breast cancer: Personal history of malignant neoplasm of the breast for the presence or recurrence of breast cancer or for additional lesions following diagnosis and/or treatment (male or female patients)

    from policy indications

    Evaluate contralateral breast with new ipsilateral cancer: To evaluate the contralateral breast in patients with a new diagnosis of breast cancer who have normal clinical and mammographic findings in the contralateral breast

    from policy indications

    Preoperative mapping for multicentric disease: For preoperative mapping of the involved (ipsilateral) breast to evaluate multicentric disease in candidates for breast-conservation therapy

    from policy indications

    Chest wall invasion assessment: To determine presence of pectoralis major muscle/chest wall invasion in patients with posteriorly located tumor

    from policy indications

    Occult primary workup: To detect suspected occult breast primary tumor in patients with axillary nodal adenocarcinoma when mammography and physical exam are negative

    from policy indications

    Neoadjuvant chemotherapy planning/assessment: For presurgical planning in locally advanced breast cancer before, during and/or after completion of neoadjuvant chemotherapy to permit tumor localization, characterize response and/or residual disease

    from policy indications

    Implant rupture: To detect a rupture of silicone or non-silicone breast augmentation or implant(s)

    from policy indications

    Pre-biopsy localization for MRI-guided biopsy: To evaluate a documented abnormality of the breast before obtaining an MRI-guided biopsy when other methods (palpation or ultrasound) cannot localize the lesion for biopsy

    from policy indications

    Experimental/Investigational / Not Medically Necessary

    Not covered (considered experimental/investigational)

    Other indications: MRI studies of the breast for all other indications are considered experimental/investigational and therefore non-covered due to insufficient scientific evidence

    policy statement

    Computer Aided Detection (CAD) including computer algorithm analysis of MRI image data for lesion detection/characterization and pharmacokinetic analysis with physician review is considered experimental/investigational and non-covered (code 0159T)

    code 0159T listed

    MRI studies of the breast that are not specifically listed in the policy’s medically necessary indications are considered experimental/investigational (E/I) and are not covered. This applies regardless of place of service; coverage is limited to the indications enumerated as medically necessary in the policy.

    Computer-aided detection for breast MRI (CPT code 0159T) is considered experimental/investigational and is not covered. In addition, any MRI of the breast performed for indications not listed as medically necessary in this policy is considered E/I and non-covered.

    Covered Indications

    High-risk screening and problem-solving indications listed under medical necessity

    High-risk screening / problem-solving indications: Known BRCA mutation, Li-Fraumeni, Cowden, Bannayan-Riley-Ruvalcaba, first-degree relative with these syndromes, high lifetime risk (≈20–25% or greater) by validated models, prior chest radiation between ages 10–30, personal history of breast cancer, evaluation of contralateral breast with new ipsilateral cancer, preoperative mapping for multicentric disease, chest wall invasion assessment, occult primary workup, neoadjuvant chemotherapy planning/assessment, implant rupture detection, pre-biopsy localization when other methods cannot localize the lesion

    Top-level grouped indications listed under medical necessity

    Coding

    Primary MRI CPT CodesCPTCovered
    77058MRI breast unilateral
    77059MRI breast bilateral
    Primary MRI CPT Codes (duplicate source listing)CPTCovered
    77058MRI breast unilateral
    77059MRI breast bilateral
    Contrast HCPCS CodesHCPCSCovered
    A9576Contrast material for MRI of breast (specific agent code listed)
    A9577Contrast material for MRI of breast
    A9578Contrast material for MRI of breast
    A9579Contrast material for MRI of breast
    CAD / Advanced AnalysisCPTNot Covered
    0159TComputer-aided detection (CAD) for MRI of the breast
    Outpatient HCPCS (C Codes)HCPCS
    C8908Outpatient MRI related HCPCS C-codes (listed in policy)
    C8904Outpatient MRI related HCPCS C-codes (listed in policy)
    C8905Outpatient MRI related HCPCS C-codes (listed in policy)
    C8906Outpatient MRI related HCPCS C-codes (listed in policy)
    C8907Outpatient MRI related HCPCS C-codes (listed in policy)

    Provider Actions / Billing Rules

    Prior Authorization

    Pre-payment application for Professional claims

    This policy is applied on a pre-payment basis for professional claims; process professional (non-facility) MRI of the breast claims as pre-payment. Refer to operational guidelines for post-payment applications noted in the bulletin.

    • Applies to Professional claims (pre-payment)
    Documentation Required

    Provider actions — documentation and member agreements

    Follow the policy’s provider requirements: obtain and retain advance written notice and signed cost agreement when a service is determined experimental/investigational and the member agrees to assume financial responsibility; submit documentation to support medical necessity when required (see CT vs MRI same-day rule).

    • Maintain signed advance written notice and cost agreement in provider records if member agrees to pay for E/I service.

    Prior Authorization / Claim Edits

    Prior Authorization

    MRI — professional pre-payment and documentation requirement for same-day CT

    Policy is applied on a pre-payment basis for professional claims; documentation may be required to justify payment when MRI and CT of the same anatomic area are performed on the same day.

    • Professional claims are pre-payment; facility guidance is provided separately.
    • If MRI and CT are same-day for same anatomy, submit documentation to justify payment for MRI.

    Contrast Material Payment Rules

    Billing Rule

    Contrast payment rule — contrast reimbursed in addition to MRI when provider-administered outside hospital/skilled facility

    Payment is made for contrast material in addition to the MRI procedure when the contrast is used with an eligible imaging procedure and is administered by the health care professional in a setting other than a hospital or skilled facility.

    • Contrast HCPCS codes listed: A9576, A9577, A9578, A9579.
    • Contrast is payable in addition to MRI when administered by the provider in non-hospital/non-skilled facility settings.

    Not Covered

    Not covered: Computer-aided detection (0159T) for MRI of the breast, including computer algorithm analysis of MRI image data for lesion detection/characterization and pharmacokinetic analysis with physician review, is considered experimental/investigational and therefore non-covered. Also explicitly non-covered are MRI studies of the breast for any indications not listed in the policy’s medically necessary criteria.

    Background

    Breast MRI produces detailed cross-sectional images and is a complementary imaging modality rather than a routine screening tool for the general population. It is used for specific high-risk screening and problem-solving indications such as evaluating known hereditary risk (including BRCA mutations and related syndromes), assessing the presence or recurrence of breast cancer, local staging or preoperative mapping (including evaluation for multicentric disease or chest wall invasion), detecting occult primary tumors when mammography and exam are negative, assessing response to neoadjuvant chemotherapy, evaluating implant rupture, and localizing lesions prior to MRI-guided biopsy when other methods cannot localize the abnormality. Risk estimation tools referenced by the policy include the Claus, modified Gail, Tyrer-Cuzick and BRCAPRO models.

    Definitions

    High risk — Definition and examples
    DefinitionHigh risk: lifetime risk about 20% to 25% or greater of developing breast cancer as identified by risk models largely defined by family history.
    Risk models (examples)Claus, modified Gail, Tyrer-Cuzick, BRCAPRO.
    Primary driverRisk estimations are largely defined by family history (including known BRCA1/BRCA2 mutations and familial cancer syndromes).
    Clinical applicationUsed to identify candidates for high‑risk breast MRI screening and other covered indications under this policy.
    ThresholdApproximately 20%–25% lifetime risk (>=20%).

    Revision History

    2016-09-26RevisionLatest

    Issue date updated to September 26, 2016 and policy effective date reflected as September 26, 2016.

    2016-03-07Effective Date

    Policy originally effective March 7, 2016 (initial publication of MRI of the Breast policy X-44).

    2016-02-01Content Update
    Policy Summary
    PayerHighmark Pennsylvania
    PolicyMagnetic Resonance Imaging (MRI) of the Breast
    Policy CodePolicy X-44
    Change TypeNo material change
    Effective DateMar 7, 2016
    Last ReviewMar 7, 2016
    Next Review DateN/A
    Key ActionSubmit professional claims on a pre-payment basis and provide documentation when MRI and CT of the same anatomic area are performed the same day to justify payment for both studies.
    SourceLink
    On This Page
    Coverage CriteriaCovered IndicationsCodingProvider Actions / Billing RulesPrior Authorization / Claim EditsContrast Material Payment RulesNot CoveredBackgroundDefinitionsRevision History
  1. Submit supporting documentation to establish medical necessity when requested.
  2. Billing Rule

    Same-day MRI and CT — CT paid unless medical necessity for both documented

    When both MRI and CT of the same anatomic area are performed the same day, payment is made for the CT; the MRI will only be paid if supporting documentation is submitted to establish medical necessity for both studies.

    • If claiming payment for same-day MRI in addition to CT, include documentation demonstrating medical necessity for both procedures.
    Denial Risk

    Denial risk for services not meeting criteria — E/I designation and member billing rules

    Services that do not meet this policy’s criteria will be considered experimental/investigational (E/I) and may be denied. A network provider may bill the member only after providing advance written notice with an estimate of cost and obtaining the member’s signed agreement assuming financial responsibility; keep the signed agreement in records.

    • E/I services are not covered regardless of place of service.
    • Provider must give advance written notice and obtain written member agreement before billing the member.

    Clinical Policy Management Committee and consultants review noted in February 2016 leading to new criteria for MRI of the Breast (document change noted).